Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117568294A reveals P450 mutant for S-halohydrins. Offers green synthesis and supply chain stability for pharma intermediates.
Novel three-step asymmetric synthesis route for high-purity (S)-rivastigmine intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover novel fluorene ring compounds for efficient peptide synthesis. Enhance purity and reduce costs in pharmaceutical intermediate manufacturing with scalable liquid phase carriers.
CN117305198A reveals high-efficiency recombinant bacterium method for L-Dopa. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN116713034B reveals organic photocatalyst for KIP. High yield, mild conditions, cost reduction in vitamin E intermediate manufacturing.
Patent CN102766081A reveals a green, solvent-free route for bis-indolylmethane derivatives using reusable ionic liquids, offering significant cost and supply chain advantages.
Novel Lewis acid catalyzed route for Everolimus reduces steps and improves purity. Ideal for pharmaceutical intermediates supply chain cost reduction and scale-up.
Novel Reppe synthesis route for strawberry acid using Rh-catalysis. High yield, green chemistry, cost-effective manufacturing for flavor industry.
Patent CN114908129B reveals a novel dehydrogenase mutant for high-purity (R)-4-chloro-3-hydroxybutyric acid ethyl ester production, offering significant cost and supply chain advantages.
Novel epoxidation reagent replacing toxic dimethyl sulfide. Recyclable, water-soluble, high yield. Reliable supplier for pharmaceutical intermediates.
Novel synthesis method for anti-HIV active derivatives offering stable quality and scalable production for pharmaceutical intermediates ensuring supply chain reliability.
Novel patent CN117105977A enables mild synthesis. Reduces costs and improves supply chain reliability for high-purity intermediates.
Patent CN110914417B reveals high-activity transaminase for chiral amine synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel catalytic method for azoxystrobin intermediate ensures high purity and selectivity. Optimized for scalable agrochemical manufacturing and supply chain reliability.
Advanced synthesis of 2-chloro-4-(4-chlorophenoxy)-acetophenone via patent CN113816838A. Delivers high purity, optimized solvent recovery, and cost-effective manufacturing for global agrochemical supply chains.
Patent CN103214455A reveals a mild hypochlorite oxidation route for Bilastine, offering high yield and purity for reliable pharmaceutical intermediate supply chains.
Novel two-step process from catechol offers high purity veratraldehyde, reducing costs compared to vanillin routes for pharma intermediates.
Discover the CN110699345A patent technology for enhanced stereoselectivity in chiral epoxide synthesis. Reliable supplier for pharmaceutical intermediates with cost-effective biocatalytic solutions.
Patent CN112573996B reveals a novel copper-catalyzed route for high-purity L-menthol. Discover cost-effective manufacturing and scalable supply chain solutions.
Novel rare-earth arylamine compounds enable high-yield synthesis. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing globally.